SCHEMBL8287201

SCHEMBL8287201

CON(C)C(=O)c1cc2c(cn1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 5/20 0.34
CDK4 P11802 2/20 0.34
CCND1 P24385 2/20 0.34
MAT2A P31153 2/20 0.34
CCND2 P30279 1/20 0.34
CCND3 P30281 1/20 0.34
MAPT P10636 3/20 0.33
CSF1R P07333 1/20 0.33
EGFR P00533 1/20 0.32
BTK Q06187 1/20 0.32
MAPK8 P45983 1/20 0.32
GSK3A P49840 2/20 0.32
PDE11A Q9HCR9 1/20 0.32
CYP1A2 P05177 3/20 0.32
CYP3A4 P08684 3/20 0.32
MEN1 O00255 2/20 0.32
ALDH1A1 P00352 2/20 0.32
KMT2A Q03164 2/20 0.32
CYP2C9 P11712 2/20 0.31
CYP2C19 P33261 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287486 0.85 LMNA (0.37) GSK3BCDK4CCND1MAT2ACCND2
SCHEMBL8286468 0.84 GSK3B (0.38) GSK3BCDK4CCND1MAT2ACCND2
SCHEMBL8287593 0.84 GSK3B (0.37) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287205 0.83 GSK3B (0.37) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287920 0.82 CSF1R (0.37) GSK3BCDK4CCND1MAT2ACCND2
SCHEMBL8362924 0.82 GSK3B (0.39) GSK3BCDK4CCND1MAT2ACCND2
SCHEMBL8286472 0.81 EGFR (0.46) MAT2AMAPTEGFRALDH1A1KMT2A
SCHEMBL8287526 0.81 MAPK13 (0.38) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287930 0.81 CSF1R (0.47) MAT2AMAPTCSF1RMEN1ALDH1A1
SCHEMBL8285291 0.81 GABRA1 (0.40) GSK3BCDK4CCND1MAT2ACCND2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed